Imfinzi

Imfinzi ATC Classification

Manufacturer:

AstraZeneca

Distributor:

Zuellig Pharma
Full Prescribing Info
ATC Classification
L01XC28 - durvalumab ; Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in